CNTX NASDAQ
Context Therapeutics Inc.
1W: -10.4%
1M: -14.6%
3M: -51.4%
YTD: -80.0%
1Y: -68.1%
3Y: -76.0%
$0.31
-0.00 (-1.49%)
Weekly Expected Move ±8.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships5
As Filer
counterparties named
1
As Counterparty
mentioned by others
2
Rel. Types
2022-08-02
Earliest Filing
2025-10-24
Latest Filing
partner: 4
acquirer: 1
Counterparties (Filed by CNTX)
5 relationshipsCompanies named in CNTX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Leerink Partners LLC | — | partner | Agent for the Company's at-the-market stock sales agreement | 2025-10-24 | View |
| Leerink Partners LLC | — | partner | Entered into a Sales Agreement to act as agent for the at-the-market offering of common stock. | 2024-12-02 | View |
| BioAtla, Inc. | BCAB | partner | Context Therapeutics Inc. entered into an exclusive worldwide license agreement to develop, manufacture, and commerciali | 2024-09-23 | View |
| Link (assignment for the benefit of creditors), LLC | — | acquirer | Seller of CT-95 assets to Context Therapeutics Inc. | 2024-07-10 | View |
| Berlin-Chemie AG - Menarini Group | — | partner | Clinical Trial Collaboration and Supply Agreement for elacestrant in combination with ONA-XR | 2022-08-02 | View |
Mentioned As Counterparty
1 mentionsOther companies that named CNTX in their SEC 8-K filings.
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Regulation FD; Exhibits | View | |
| 2026-07-31 | Delisting Notice | View | |
| 2026-06-26 | Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-06-15 | Regulation FD; Other Events; Exhibits | View | |
| 2026-05-18 | Material Agreement; Regulation FD; Exhibits | Agreement | View |
| 2026-05-01 | Other Events | View | |
| 2026-04-02 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-23 | Regulation FD; Other Events; Exhibits | View | |
| 2026-03-13 | Amendments to Articles of Incorporation or Bylaws; Other Events; Financial Statements and Exhibits | View | |
| 2026-02-27 | Other Events | View | |
| 2026-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-11-05 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-10-24 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
| 2025-10-20 | Other Events | View | |
| 2025-09-02 | Notice of Delisting or Transfer | View | |
| 2025-06-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-06-02 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-04-09 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-02-28 | Notice of Delisting or Transfer | View | |
| 2025-01-14 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR